Stay updated on Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the Record History.SummaryDifference0.1%

- Check29 days agoChange DetectedThe history shows a new revision v3.4.3 was added and v3.4.2 removed, updating the version history display.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision: v3.4.2 was added. The funding-notice banner and Revision: v3.4.1 were removed.SummaryDifference0.6%

- Check64 days agoChange DetectedA government funding notice banner and a software revision tag (v3.4.1) were added, with no changes to study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check71 days agoChange DetectedUI updates to the history view introduce a glossary toggle, color-coded highlights for additions (green) and deletions (red), and revised revision labels (e.g., Revision: v3.4.0) and No FEAR Act Data wording.SummaryDifference0.8%

- Check86 days agoChange DetectedRevision: v3.3.4 was added to the history and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.